Regulatory challenges and investigational device exemption protocols for fenestrated and branched EVAR in the United States. [Review] (Record no. 319)

MARC details
000 -LEADER
fixed length control field 02827nam a22003857a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 221018s20222022 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0895-7967
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1053/j.semvascsurg.2022.07.008 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code S0895-7967(22)00053-9 [pii]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 36153078
245 ## - TITLE STATEMENT
Title Regulatory challenges and investigational device exemption protocols for fenestrated and branched EVAR in the United States. [Review]
251 ## - Source
Source Seminars in Vascular Surgery. 35(3):374-379, 2022 Sep.
252 ## - Abbreviated Source
Abbreviated source Semin Vasc Surg. 35(3):374-379, 2022 Sep.
253 ## - Journal Name
Journal name Seminars in vascular surgery
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2022
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2023
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Publication date 2022 Sep
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status ppublish
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Medline status In-Process
266 ## - Date added to catalog
Date added to catalog 2022-10-20
520 ## - SUMMARY, ETC.
Abstract The US Food and Drug Administration (FDA) was created with the intent to ensure the safety of consumers in the United States. During the 1970s, this mandate was expanded to include medical devices. Aortic endografts, implanted since the 1990s, fall under this purview. Industry-sponsored and physician-sponsored investigation of the efficacy and safety of these devices is critical to the ongoing development of interventions for complex aortic anatomy. This research, in accordance with federal rules and regulation, must be conducted in coordination and with the approval of the FDA. The FDA has designed a process for which manufacturers or investigators may conduct efficacy and safety research using new or modified devices with oversight by the federal government. To conduct this type of research, an investigational device exemption must be obtained from the FDA. An investigational device exemption, although useful from a regulatory perspective, places a large time and financial responsibility on the investigator. As it stands now, the regulatory environment limits research into fenestrated and branched endovascular aortic repair to only those physicians and manufacturers able to provide the significant number of resources required to complete the laborious pre-application, application, and ongoing reports associated with obtaining and maintaining an investigational device exemption. Copyright © 2022. Published by Elsevier Inc.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Vascular Surgery Integrated Residency
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
657 ## - INDEX TERM--FUNCTION
Medline publication type Review
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Fatima, Javairiah
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Rossi, Matthew
Institution Code MWHC
Program Vascular Surgery Integrated Residency
Degree MD
Resident year Resident PGY 5
790 ## - Authors
All authors Fatima J, Rossi MJ
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1053/j.semvascsurg.2022.07.008">https://dx.doi.org/10.1053/j.semvascsurg.2022.07.008</a>
Public note https://dx.doi.org/10.1053/j.semvascsurg.2022.07.008
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 10/20/2022   36153078 36153078 10/20/2022 10/20/2022 Journal Article

Powered by Koha